PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT03618030 · COMPLETED
Trial details
- NCT number
- NCT03618030
- Sponsor
- Purdue Pharma, Canada
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2019-07-05
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.